General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0TUZRP
ADC Name
BL-M002A2
Synonyms
BL-B002A2; BL-M002; BL M002; BLM002
   Click to Show/Hide
Organization
Systimmune, Inc.; Sichuan Baili Pharmaceutical Co., Ltd.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Glioblastoma
Clinical candidate
.
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed